Phillip Brady Hayden

CIK 1938940 · View on SEC EDGAR ↗

Insider

First SEC filing: May 31, 2024 · Latest: June 16, 2026

On this page

Insider at

Insider transactions

0 buys (P) 1 sells (S) Net: $-77,824 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 12, 2026 CURI S 30,400 $2.56 $77,824 71,267 Indirect -29.90% Disposed 12.1% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
July 24, 2026 CURI Restricted Stock Units Common Stock (17,500) 17,500 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
May 31, 2024 CURI Common Stock 1,000 Indirect
May 31, 2024 CURI Common Stock 24,000 Indirect
May 31, 2024 CURI Restricted Stock Units→ Common Stock (25,000) 25,000 Direct
May 31, 2024 CURI Restricted Stock Units→ Common Stock (50,000) 50,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CURI

CFO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $240,000 $284,725 $180,000 $10,000 $714,725
2024 $203,750 $356,175 $92,744 $8,150 $660,819

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.